Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders

• 收藏
• 分享

专利权人:

Inc.;KAI Pharmaceuticals

发明人:

Bell, Gregory,Karim, Felix,Walter, Sarah

申请号：

AU2007325387

公开号：

AU2007325387B2

申请日:

2007.11.16

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

The present invention provides methods and kits for treating hyperparathyroidism,bone disease and/or hypercalcemic disorders. In particular, methods for loweringserum PTH and serum calcium using polycationic calcium modulator peptides areprovided. The calcium modulator peptides can be used to treat subjects having,for example: primary, secondary or tertiary hyperparathyroidism； hypercalcemiaof malignancy； metastatic bone disease； or osteoporosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/